FindTrial
Sign In

A Randomised trial of Adjuvant Chemotherapy in Oesophago-Gastric Cancer

A Randomised trial of Adjuvant Chemotherapy in Oesophago-Gastric Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN81192724
Enrollment
Unknown
Registered
2002-08-19
Start date
2000-01-01
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oesophagus, Stomach Cancer Oesophagus, Stomach

Interventions

1. ECF - 5FU 200 mg/m2 continuous infusion Epirubicin 50 mg/m2 3-weekly IV bolus Cisplatin 60 mg/m2 3 weekly 2. Best supportive care (no treatment)

Sponsors

The Royal Marsden NHS Foundation Trust (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Histological squamous or adenocarcinoma of oesophagus or adenocarcinoma of stomach 2. Disease completely resected - no evidence of metastases after staging investigations 3. Surgery within the past 16 weeks

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

MeasureTime frame
Not provided at time of registration—

Secondary

MeasureTime frame
Not provided at time of registration—

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026